1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone

C118H173N19O8 — CID 158719013

IUPAC1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone
SMILESCN1CCN(C(=O)CC23CC4CC(C2)CC(c2ccccc2)(C4)C3)CC1.Cc1ncn(C23CC4CC(CC(CC(=O)NCC(C)N5CCOCC5)(C4)C2)C3)n1.Cc1nn(C)c(C)c1C12CC3CC(CC(CC(=O)NCC(C)N4CCOCC4)(C3)C1)C2.O=C(CC12CC3CC(C1)CC(c1ccccc1)(C3)C2)NCCN1CCOCC1.O=C(CC12CC3CC(C1)CC(n1cncn1)(C3)C2)N1CCN(Cc2ccccn2)CC1
InChIInChI=1S/C25H40N4O2.C24H32N6O.C24H34N2O2.C23H32N2O.C22H35N5O2/c1-17(29-5-7-31-8-6-29)15-26-22(30)14-24-10-20-9-21(11-24)13-25(12-20,16-24)23-18(2)27-28(4)19(23)3;31-22(29-7-5-28(6-8-29)15-21-3-1-2-4-26-21)14-23-10-19-9-20(11-23)13-24(12-19,16-23)30-18-25-17-27-30;27-22(25-6-7-26-8-10-28-11-9-26)17-23-13-19-12-20(14-23)16-24(15-19,18-23)21-4-2-1-3-5-21;1-24-7-9-25(10-8-24)21(26)16-22-12-18-11-19(13-22)15-23(14-18,17-22)20-5-3-2-4-6-20;1-16(26-3-5-29-6-4-26)13-23-20(28)12-21-8-18-7-19(9-21)11-22(10-18,14-21)27-15-24-17(2)25-27/h17,20-21H,5-16H2,1-4H3,(H,26,30);1-4,17-20H,5-16H2;1-5,19-20H,6-18H2,(H,25,27);2-6,18-19H,7-17H2,1H3;15-16,18-19H,3-14H2,1-2H3,(H,23,28)
InChIKeyIJRFHSJADIFBDG-UHFFFAOYSA-N
MW1985.81 g/mol
LogP14.97
Rot. Bonds26

About 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone

1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone (PubChem CID 158719013) has the molecular formula C118H173N19O8 and a molecular weight of 1985.81 g/mol. Its IUPAC name is 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone.

Molecular Properties

Compound Name1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone
PubChem CID158719013
Molecular FormulaC118H173N19O8
Molecular Weight1985.81 g/mol
Exact Mass1984.37
IUPAC Name1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone
SMILESCN1CCN(C(=O)CC23CC4CC(C2)CC(c2ccccc2)(C4)C3)CC1.Cc1ncn(C23CC4CC(CC(CC(=O)NCC(C)N5CCOCC5)(C4)C2)C3)n1.Cc1nn(C)c(C)c1C12CC3CC(CC(CC(=O)NCC(C)N4CCOCC4)(C3)C1)C2.O=C(CC12CC3CC(C1)CC(c1ccccc1)(C3)C2)NCCN1CCOCC1.O=C(CC12CC3CC(C1)CC(n1cncn1)(C3)C2)N1CCN(Cc2ccccn2)CC1
InChIInChI=1S/C25H40N4O2.C24H32N6O.C24H34N2O2.C23H32N2O.C22H35N5O2/c1-17(29-5-7-31-8-6-29)15-26-22(30)14-24-10-20-9-21(11-24)13-25(12-20,16-24)23-18(2)27-28(4)19(23)3;31-22(29-7-5-28(6-8-29)15-21-3-1-2-4-26-21)14-23-10-19-9-20(11-23)13-24(12-19,16-23)30-18-25-17-27-30;27-22(25-6-7-26-8-10-28-11-9-26)17-23-13-19-12-20(14-23)16-24(15-19,18-23)21-4-2-1-3-5-21;1-24-7-9-25(10-8-24)21(26)16-22-12-18-11-19(13-22)15-23(14-18,17-22)20-5-3-2-4-6-20;1-16(26-3-5-29-6-4-26)13-23-20(28)12-21-8-18-7-19(9-21)11-22(10-18,14-21)27-15-24-17(2)25-27/h17,20-21H,5-16H2,1-4H3,(H,26,30);1-4,17-20H,5-16H2;1-5,19-20H,6-18H2,(H,25,27);2-6,18-19H,7-17H2,1H3;15-16,18-19H,3-14H2,1-2H3,(H,23,28)
InChIKeyIJRFHSJADIFBDG-UHFFFAOYSA-N
XLogP14.97
TPSA263.94 Ų
H-Bond Donors3
H-Bond Acceptors22
Rotatable Bonds26
Heavy Atoms145
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001985.81
LogP ≤ 514.97
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1022

Analyze 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-cyclopropyl-1-[1-methyl-4-[4-[[3-(trifluoromethyl)phenyl]carbamoylamino]phenyl]pyrazolo[5,4-b]pyridin-6-yl]cyclopropane-1-carboxamide;1-[4-[1-ethyl-6-(morpholin-4-ylmethyl)pyrazolo[3,4-b]pyridin-4-yl]phenyl]-3-[3-(trifluoromethyl)phenyl]urea;1-[4-[1-(2-hydroxyethyl)-6-(morpholin-4-ylmethyl)pyrazolo[3,4-b]pyridin-4-yl]phenyl]-3-[3-(trifluoromethyl)phenyl]urea;1-[4-[1-methyl-6-(piperazin-1-ylmethyl)pyrazolo[3,4-b]pyridin-4-yl]phenyl]-3-[3-(trifluoromethyl)phenyl]urea
CID 158271922
3,3-difluoro-N-[(1R,3S)-3-[[5-fluoro-2-(1-methylpyrazolo[5,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]cyclohexyl]pyrrolidine-1-carboxamide;(3R)-3-fluoro-N-[(1R)-3-[[5-fluoro-2-(5-fluoro-1-methylpyrazolo[5,4-b]pyridin-3-yl)pyrimidin-4-yl]methyl]cyclohexyl]pyrrolidine-1-carboxamide;N-[(1R)-3-[[5-fluoro-2-(5-fluoro-1-methylpyrazolo[5,4-b]pyridin-3-yl)pyrimidin-4-yl]methyl]cyclohexyl]morpholine-4-carboxamide;(2S)-N-[(1R,3S)-3-[[5-fluoro-2-(1-methylpyrazolo[5,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]cyclohexyl]-2-methylpyrrolidine-1-carboxamide;N-[(1R,3S)-3-[[5-fluoro-2-(1-methylpyrazolo[5,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]cyclohexyl]piperidine-1-carboxamide;N-[(1R)-3-[[5-fluoro-2-(1-methylpyrazolo[5,4-b]pyridin-3-yl)pyrimidin-4-yl]methyl]cyclohexyl]pyrrolidine-1-carboxamide
CID 160957594
1-[4-[1-(1-Benzoylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-(2-fluoroethyl)urea;1-methyl-3-[4-[1-[1-(2-methylbenzoyl)piperidin-4-yl]-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]urea;1-[4-[4-morpholin-4-yl-1-[1-(pyridine-3-carbonyl)piperidin-4-yl]pyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-phenylurea
CID 87605761
1-[4-[1-(1-Benzoylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-(2-hydroxyethyl)urea;1-[4-[1-(1-benzoylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-phenylurea;1-[4-[1-(1-benzoylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-pyridin-3-ylurea
CID 87605776
1-[4-[1-(1-Benzoylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-pyridin-4-ylurea;1-[4-[1-[1-(3-fluorobenzoyl)piperidin-4-yl]-4-morpholin-4-ylpyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-methylurea;1-[4-[4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]pyrazolo[5,4-d]pyrimidin-6-yl]phenyl]-3-pyridin-3-ylurea
CID 87605858
1-[4-[3-(dimethylamino)pyrrolidine-1-carbonyl]-N-[[4-[4-(3-methylpyrazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]carbamoyl]anilino]-1-[4-[4-(3-methylpyrazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-3-[4-(piperazine-1-carbonyl)phenyl]urea
CID 91026414
4-[3-[1-[4-[3-[1-[4-[2-[4-(cyclopropylmethylcarbamoyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-8-yl]benzoyl]piperidin-3-yl]-2-[4-[2-methoxyethyl(methyl)carbamoyl]anilino]-[1,2,4]triazolo[1,5-a]pyridin-3-ium-8-yl]benzoyl]piperidin-3-yl]-2-[4-(morpholine-4-carbonyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-3-ium-8-yl]-N-(pyridin-2-ylmethyl)benzamide
CID 91026836
3-Morpholin-4-yl-4-pyrazin-2-yl-5-pyridazin-3-yl-4-pyrimidin-2-yl-3-(1,3,5-triazin-2-yl)pyrrolidin-2-one
CID 91320169
6-[3-[[3-(dimethylamino)propylamino]methyl]phenyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-1-[5-[4-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methylcarbamoyl]-6-[3-[(2-morpholin-4-ylethylamino)methyl]phenyl]pyrazolo[5,4-b]pyridin-1-yl]hexan-2-yl]pyrazolo[5,4-b]pyridine-4-carboxamide
CID 123768943
7-Methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-[3-(morpholine-4-carbonyl)-1-adamantyl]purin-8-one
CID 156571262
7-Methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-[3-[[2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-[5-(morpholine-4-carbonyl)-1-tetracyclo[3.3.1.03,9.07,9]nonanyl]-8-oxopurin-7-yl]methoxymethyl]-1-adamantyl]purin-8-one
CID 156571303
9-(4,6,7,7a-tetrahydroimidazo[4,5-c]pyridin-5-yl)-3-tert-butyl-3-azaspiro[5.5]undecane;N-(1-azabicyclo[2.2.2]octan-3-yl)-3-tert-butyl-3-azaspiro[5.5]undecane-9-carboxamide;(3-tert-butyl-3-azaspiro[5.5]undecan-9-yl)-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl)methanone;2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane
CID 157083041

Frequently Asked Questions

What is the IUPAC name of 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone?
The IUPAC name of 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone (CID 158719013) is 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone.
What is the SMILES notation for 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone?
The canonical SMILES for 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone is CN1CCN(C(=O)CC23CC4CC(C2)CC(c2ccccc2)(C4)C3)CC1.Cc1ncn(C23CC4CC(CC(CC(=O)NCC(C)N5CCOCC5)(C4)C2)C3)n1.Cc1nn(C)c(C)c1C12CC3CC(CC(CC(=O)NCC(C)N4CCOCC4)(C3)C1)C2.O=C(CC12CC3CC(C1)CC(c1ccccc1)(C3)C2)NCCN1CCOCC1.O=C(CC12CC3CC(C1)CC(n1cncn1)(C3)C2)N1CCN(Cc2ccccn2)CC1.
What is the InChIKey of 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone?
The InChIKey is IJRFHSJADIFBDG-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H40N4O2.C24H32N6O.C24H34N2O2.C23H32N2O.C22H35N5O2/c1-17(29-5-7-31-8-6-29)15-26-22(30)14-24-10-20-9-21(11-24)13-25(12-20,16-24)23-18(2)27-28(4)19(23)3;31-22(29-7-5-28(6-8-29)15-21-3-1-2-4-26-21)14-23-10-19-9-20(11-23)13-24(12-19,16-23)30-18-25-17-27-30;27-22(25-6-7-26-8-10-28-11-9-26)17-23-13-19-12-20(14-23)16-24(15-19,18-23)21-4-2-1-3-5-21;1-24-7-9-25(10-8-24)21(26)16-22-12-18-11-19(13-22)15-23(14-18,17-22)20-5-3-2-4-6-20;1-16(26-3-5-29-6-4-26)13-23-20(28)12-21-8-18-7-19(9-21)11-22(10-18,14-21)27-15-24-17(2)25-27/h17,20-21H,5-16H2,1-4H3,(H,26,30);1-4,17-20H,5-16H2;1-5,19-20H,6-18H2,(H,25,27);2-6,18-19H,7-17H2,1H3;15-16,18-19H,3-14H2,1-2H3,(H,23,28).
What are the key properties of 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone?
1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone has a molecular weight of 1985.81 g/mol, XLogP of 14.97, 26 rotatable bonds, 3 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(4-methylpiperazin-1-yl)-2-(3-phenyl-1-adamantyl)ethanone;2-[3-(3-methyl-1,2,4-triazol-1-yl)-1-adamantyl]-N-(2-morpholin-4-ylpropyl)acetamide;N-(2-morpholin-4-ylethyl)-2-(3-phenyl-1-adamantyl)acetamide;N-(2-morpholin-4-ylpropyl)-2-[3-(1,3,5-trimethylpyrazol-4-yl)-1-adamantyl]acetamide;1-[4-(pyridin-2-ylmethyl)piperazin-1-yl]-2-[3-(1,2,4-triazol-1-yl)-1-adamantyl]ethanone is sourced from PubChem (CID 158719013), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).